An important consequence of the suicide gene therapeutic paradigm is the phenomenon of bystander cell killing, the death of adjacent tumor cells not transduced with the thymidine kinase ( TK ) gene from herpes simplex virus ( HSV ) after treatment with the antiviral drug, ganciclovir ( GCV ). Evidence from quantitative in vitro assays of glioma cell lines suggest that both murine and human gliomas are similar in expressing high sensitivity to the bystander effect. In five of six glial tumors examined, the presence of only 5% of HSV -TK -expressing transduced cells in the culture resulted in > 90% tumor cell death / stasis after addition of GCV. Several lines of evidence support gap junction intercellular communication ( GJIC ) as important in the bystander effect. In vitro metabolic assays, performed with GCV in the medium, indicated that more tumor burden was reduced when culture conditions supported cell -cell contact of parental and HSV -TK -transduced cells. Additionally, a double dye transfer assay showed that cell communication through the gap junction is greatest for glioma, less for melanoma, and much less for colorectal carcinoma cell lines. In vitro metabolic assays with mixtures of TK + / TK À homologous tumor cells confirmed that glioma cell lines were more susceptible to bystander killing than melanomas. Assays with chimeric tumor mixtures of TK + / TK À cells showed that the level of the bystander killing obtained was characteristic of the TK À bystander cells. The in vitro findings were confirmed in vivo with GCV -treated homologous and chimeric tumors composed of TK + / TK À cells. Day 21 mean tumor volumes ( MTVs ) indicated the growths obtained were characteristic of the bystander activity reflective of the nontransduced cell population. Furthermore, nontransduced, high -GJIC cells in a chimeric tumor mass appeared to effectively bridge between transduced tumor cells and poorly communicating nontransduced cells. Finally, the importance of a gap junction protein, such as connexin -43, in facilitating the bystander effect was demonstrated with the HT29 low -GJIC cell line. When the TK -nontransduced cell population expressed connexin -43, a better bystander kill was achieved compared to the parental counterpart.
A lthough tumor burden can be reduced by surgery, radiation, and chemotherapy, an effective and complete treatment for malignant brain tumors has to date remained elusive. 1 The tumors often recur because their heterogeneous nature allows tumor escape from treatment and because of their infiltrative properties. 2, 3 Suicide gene therapy using the thymidine kinase (TK ) gene from HSV has engendered great interest in recent years for the treatment of malignant gliomas. Strategies involving implantation of retroviral producer cells or purified, high -titer retroviral vector particles have shown promise in preclinical and clinical studies; however, it has become clear that current technologies do not enable transfer of the therapeutic transgene to sufficient malignant cells within a solid tumor mass to produce curative effects. Promise of a viable treatment is suggested by the now numerous experimental suicide gene therapy studies demonstrating a bystander killing effect for tumor cells. 4 -7 Briefly, in the in vitro paradigm the herpes simplex virus thymidine kinase ( HSV-TK ) gene is transferred into active tumor cells by viral vectors. During later treatment with the antiviral agent, ganciclovir ( GCV ), both tumor cells expressing HSV-TK and also neighboring tumor cells not expressing HSV-TK are killed. Thus, through the mechanism of bystander cell death, tumor eradication may be possible without the necessity of transferring HSV-TK into every tumor cell. The intoxication of nontransduced bystander cells is believed to result from a gap junction intercellular transfer of toxic phosphorylated GCV molecules from the cytoplasm of HSV-TK -transduced cells to nontransduced cells by a family of connexin proteins.
In previous papers we reported a dramatic effect of the bystander killing mechanism both in vitro and in vivo for murine 9L gliosarcoma cells. 10, 11 In the current paper we (1 ) extend the observations made on bystander effect to several more murine as well as human glioma cell lines, (2 ) report the effect of cell density on the bystander effect, (3 ) quantify the relative gap junction intercellular communication ( GJIC ) among glioma, melanoma, and colorectal carcinoma cell lines, (4 ) examine the relative sensitivity of gliomas to bystander cell death compared to melanoma, (5 ) explore, both in vitro and in vivo, the effects of mixing various HSV-TK -transduced with nontransduced cell lines displaying differential bystander effects to determine if the nontransduced bystander population can be effectively bridged with HSV-TK + cells to produce an increased level of bystander cell death, and (6 ) explore bystander effects with tumor mixtures that are HSV-TK transduced and/ or connexin-43 ( Cx43 ) transduced.
Methods

Vector preparation
Details of the construction of the murine HSV-TK retroviral provector, the method used to generate retroviral packaging cell lines that minimizes formation of replication competent retrovirus, and the method to produce high -titer amphotropic vector involving selection, dilution cloning, and screening are as previously described. 10 The expansion of the hightiter producer clones in 85,000 -cm 2 Cell Cube 2 culture vessels (Corning CoStar, Cambridge, MA ) and their concentration by tangential flow ultrafiltration is also described in more detail. 10 The cloning methods for obtaining a Cx43 retroviral vector were the same as for the HSV-TK gene except at the point where the cDNA for Cx -43 (American Type Culture Collection, Manassas, VA ) was substituted in place of that for HSV-TK.
Cell culture
Glioma cells (human MG1, MG2, MG3, T98, U -87, U -138, U -373 and rat C6, CNS -1, 9L ) were cultured in RPMI 1640:Dulbecco's modified Eagle's medium (2:1 vol /vol, MA Whitaker Biologicals, Walkersville, MD ) containing 10% fetal calf serum ( Gibco, Grand Island, NY ), 2 mM Lglutamine, 1 mM sodium pyruvate, 100 M nonessential amino acids, 100 U /mL penicillin, and 0.1 mg /mL streptomycin (pH 7.2 ). Melanoma cells (A2058, DM13, DM12, DM92, DM93, M24, C8161, DM150 ) and colorectal carcinoma cells (CaCo2, WiDr, SW480, SW827, SW948, HT29, LS174T, HCT116, Lovo ) were grown in Dulbecco's modified Eagle's medium containing the same additives. Control cell populations transduced with either the HSV-TK or the Cx43 retroviral vectors, or both, were selected to homogeneity in medium containing geneticin sulfate (G418, 400 g /mL effective concentration, Life Technologies, Grand Island, NY ). Expression of HSV-TK in 100% of cells was confirmed by intracellular immunofluorescence staining and FACS analysis as described previously, 10 at which point the cell line was assigned the -TK designation ( e.g., DM12-TK ). Cx -43 expression by the HT29 selected cells was verified by immunoblot analyses utilizing the methods and anti-Cx43 polyclonal antibody as described previously.
12 HT29 -TK cells were also subsequently transduced with the Cx43 retroviral vector, and the double transductants were designated HT29 -Cx43TK.
Quantitative in vitro assay for bystander killing in glioma or melanoma tumors using parental cell lines with HSV -TK -transduced cells and GCV Various percentages of 100% HSV-TK -transduced cells ( 0%, 2%, 5%, 20%, 60%, and 100% ) were admixed with a parental cell line. The mixtures were seeded in triplicate at a total of 3Â10 4 cells/well into a 96-well tissue culture plate and grown overnight. For the experiment involving the C6 cell line plated at 100% or 10% confluence, another set of cell mixtures was plated, but at a 1:10 dilution of the above cell concentration. The first set of cell admixtures plated at higher concentration was to measure cumulative C6 cell killing by GCV and bystander effects; the lower concentration of cells in the second plate was to measure largely C6 cell killing by GCV alone. For the experiment exploring the role of gap junction proteins in facilitating bystander effect with the HT29 cell line, 20% HT29 -TK cells or 20% HT29 -Cx43TK cells were mixed with either parental HT29 or with HT29 -Cx43 cells. For all the quantitative assay experiments, the cells were then exposed to GCV-containing medium at a concentration of 10 g /mL for 24 hours. The medium was aspirated, the monolayers were washed once with phosphate -buffered saline (PBS ) solution and trypsinized, washed with fresh complete medium prewarmed to 378C, split 1:10, and cultured for 5 days. Relative metabolic activity was then estimated using a CellTiter 96 AQ kit ( Promega, Madison, WI ) according to the manufacturer's instructions. This colometric cell proliferation assay measures viable cell dehydrogenase activity.
Double dye transfer assay for GJIC
In this assay cells from the same line were loaded with different dyes: calcein -AM and octadecyl rhodamine. Cells from a semiconfluent flask ( ca. 2Â10 5 ) were labeled with calcein-AM (1 g /mL, Molecular Probes, Eugene, OR, C1430) in PBS containing 10 mM glucose, 30 mM HEPES buffer, and 0.1% bovine serum albumin ( calcein loading buffer ). The flask was incubated in the dark for 30 minutes at room temperature. The second flask of cells was incubated at 378C for 30 minutes with octadecyl rhodamine B (2.5 g/ mL, Molecular Probes R18 0 -246 ) in culture medium. At the end of the incubation period, the dye containing incubation buffer/medium was removed, the cells washed once with PBS, then the cells trypsinized and collected by centrifugation at 200Âg for 15 minutes. The dye -labeled cells were combined and resuspended in 1 mL of medium and an aliquot placed into PBS containing 0.2% sodium azide and 0.2% bovine serum albumin (FACS buffer ). This baseline T0 sample was analyzed immediately by flow cytometry ( FacScan ), and the gates were set under the assumption no mixing occurred. The remaining cells were divided equally into wells of a 12 -well plate and allowed to adhere for 6 hours. At the end of this incubation period, the monolayers were washed three times in PBS, then trypsinized. Detached cells were added directly to FacScan tubes containing 0.5 mL FACS buffer and read within 1 hour to obtain an FL -1 versus FL -2 dot plot. The calcein ( green shift) indicated the percentage of cells competent for calcein transfer and hence, GJIC. The data from a panel of glioma, melanoma, and colorectal carcinoma cell lines were grouped and the average percentages of communicating cells± standard error ( SE ) were calculated.
In vivo comparison of antitumor activity of GCV in mixed tumors comprised of varying ratios of HSV -TK -transduced and nontransduced cells, displaying high and low bystander effects Twelve groups (n =5 ) of BALB /c nude mice were given subcutaneous tumor cell injections (10 6 ) in the right hind flank with various mixtures of HSV-TK -transduced tumor cells mixed with parental or nonparental cell lines, which displayed differential susceptibility to bystander effects.
In 8 of the 12 groups, and in two separate experiments, the parental tumor cells were mixed at varying percentages with cells of the HSV-TK -transduced counterpart (0, 5, 25 or 50, and 100). Half of the eight groups of mice were injected with tumor composed of cells found to have a high (CNS -1 ) bystander cell killing sensitivity, and the other half were injected with cells found to have a low (DM12) bystander killing effect.
In the remaining four groups, tumor injections were composed of mixed cell lines. In one group, 95% of CNS -1 cells were mixed with 5% DM12-TK cells. For another group, 95% of DM12 cells were mixed with 5% CNS -1-TK cells. A third group was given 75% of DM12 cells mixed with 25% DM12-TK cells, and a fourth group was given 75% DM12 plus 20% CNS -1 cells mixed with 5% DM12-TK.
Seven days after subcutaneous injection the mice tumor volumes were measured by caliper, and only those with tumor between 20 and 50 mm 3 were integrated into the experimental groups. Then, each of the animals were given daily intraperitoneal injections of GCV (62.5 mg /kg /d) that continued for 14 days. At day 21 following the initial subcutaneous tumor injection, each animal was inspected for evidence of tumor, and values of mean tumor volumes ( MTV ± SE ) were calculated for each group using caliper measurements of tumor tissue. Such measurements were confirmed by resecting the tissue and obtaining wet weights of the tissue.
Results
Comparison of murine and human glioma cell lines by quantitative in vitro assay for bystander effects
In Figure 1 , the proportion of glioma tumor burden susceptible to GCV-mediated cell killing / stasis plus bystander effects is described for three rat and three human glioma cell lines. Among the murine cells (C6, CNS -1, 9L ) reduction of tumor burden ( black bars ) by >90% was evident when as few as 5% HSV-TK -transduced cells were present. A similar reduction in tumor burden was found for two of the three human cell lines ( MG1, MG3) when only 5% TK positive cells were in the admixtures. For the MG2 cell line, although clear bystander killing effects were evident, a higher proportion of MG2 -TK cells was required to achieve a significant tumor reduction. Cumulatively, the results of the quantitative in vitro assay suggest that both murine and human glioma cell lines are strongly susceptible to bystander killing effects.
Quantitative in vitro assay to establish the role of cell -cell contact in bystander killing of the C6 glioma cell line
An assay was performed to assess what proportion of the C6 tumor burden was susceptible to GCV-mediated killing / stasis versus that due to GCV-mediated killing /stasis plus bystander killing. An assay was conducted with cells plated at high density, where cell -cell contact would allow for gap junction -type phenomenon, and with cells sparsely plated, such that only GCV-mediated killing likely would occur. In (Fig 2A, 100%  confluence ) show that the bystander effect on C6 cells is quite high, because as little as 2% C6 -TK cells in the admixture reduced tumor burden by more than 60%. Bystander effects were also observed with cell admixtures plated at low density ( Fig 2B, 10% confluence ) where cell to cell contact would be at a minimum. At 2% C6 -TK mixtures, approximately 40% elimination of tumor burden was obtained. Although cell -cell contact maximizes bystander effects, remarkably, detectable bystander effects were seen with C6 -TK cells in the admixtures plated at low cell density.
Assessment of GJIC
To investigate the GJIC in tumor cells, a double dye labeling procedure was applied to several types of tumor cell lines.
The results are summarized in Figure 3 , where the amount of dye transfer, and by inference the relative GJIC, is shown for panels of melanoma, glioma, and colorectal carcinoma cell lines. The percent communicating cells, derived from the mean amount of dye transfer, for the glioma cell lines was 65.3 ± 8.0 (n = 8). It was lower for the melanoma cell lines ( 45.8 ±9.3, n= 7 ), and even less for the colorectal carcinoma cell lines ( 12.2± 7.1, n= 9). The results of the double dye transfer assay indicate that gliomas may be more amenable to gene therapy with HSV-TK / GCV because of the remarkable GJIC displayed by the cells.
In vitro comparison of bystander cell killing effects with mixtures of cell lines having differential bystander sensitivity
Another set of quantitative in vitro assays were performed to assess what proportion of the tumor burden was susceptible to GCV-mediated killing /stasis in cultures composed of various mixtures of cell lines known to be susceptible to the HSV-TK paradigm. Table 1 the resultant cell death has the characteristic of the nontransduced low bystander cell line ( columns 6 and 8 ). Conversely, when a low bystander HSV-TK -transduced cell line is mixed with a nontransduced high bystander effect cell line, the cell death has the characteristic of the nontransduced high bystander cell line (columns 2 and 4).
These findings are reinforced by additional in vitro quantitative assays shown graphically in Figure 4 , where the human MG1 -TK glioma cell line, previously shown to have high bystander killing effects ( Fig 1) , was mixed with the parental cell line or other nonparental glioma or melanoma cell lines. When the transduced human glioma ( MG1 -TK ) was mixed with the homologous ( MG1 ) or the nonparental (CNS -1) high bystander effect glioma cell lines, the resultant metabolic activity patterns observed were characteristic of the nontransduced cells. Both mixtures demonstrated a strong bystander killing effect, characteristic of the rat glioma data in Table 1 . A low bystander killing effect, characteristic of the melanoma data in Table 1 , resulted when the MG1 -TK human glioma was mixed with either of two human melanoma cell lines ( DM12, DM93 ).
In vivo comparison of antitumor activity of GCV in mixed tumors comprised of cells with high and low bystander effects
We wanted to determine if the in vitro findings of bystander effect (being reflective of the nontransduced cell population as shown in Table 1 and Fig 4) extended to an in vivo experimental model. For that, 12 groups of BALB /c nude mice were given subcutaneous injections with various mixtures of HSV-TK -transduced tumor cells mixed with parental or nonparental cell lines, followed by later treatment with GCV. The cells implanted were previously shown to display differential susceptibility to bystander effects in vitro.
Four groups of mice were injected with DM12 -TK / DM12 tumor cell mixtures that contained 0%, 5%, 25% or 50%, and 100% of the HSV-TK -transduced cells. Four other groups of mice were similarly injected, but with CNS -1 -TK /CNS -1 tumor cells. From two separate experiments, the day 21 MTVs for the groups of mice are in Table 2 . The tumor growths mimicked the cell killing effects obtained in the in vitro bystander assays (Fig 1 and Table 1 ). Animals treated with GCV displayed greater tumor volumes when given DM12 -TK /DM12 cells displaying low bystander effect, than those animals given CNS -1 -TK /CNS -1 with high bystander effect.
Two other groups of mice were injected with (1 ) 5% DM12-TK mixed with 95% CNS -1 or (2 ) 5% CNS -1 -TK mixed with 95% DM12. Again, in vivo tumor growth was reflective of the nontransduced cells ( Fig 5 ) . That is, when low bystander effect melanoma DM12-TK -transduced cells Mixtures were cultured in the presence of GCV and later the relative metabolic activity measured as given in Materials and methods. Homologous mixtures of the melanoma cell lines, DM12 -TK / DM12 and DM93 -TK / DM93, displayed metabolic activities reflective of low and moderate bystander effects, whereas mixtures of the glioma cell lines, C6 -TK / C6 and CNS -1 -TK / CNS -1, displayed those reflective of high bystander effects. Chimeric tumor mixtures displayed metabolic activities characteristic of the nontransduced cell population. were mixed with high bystander effect nontransduced CNS -1 cells, tumor volume was zero. Conversely, when glioma CNS -1 -TK -transduced cells were mixed with nontransduced melanoma cells, measurable tumor volumes ( MTV 34 ± 26) were obtained. Two other groups of animals were given 25% DM12-TK mixed with 75% DM12 parental cells or 5% DM12-TK mixed with 20% CNS -1 glioma plus 75% DM12 melanoma nontransduced cells. In Figure 5 the MTVs obtained for these groups are consistent with the concept of the bystander effect being characteristic of the nontransduced population of cells. These data would be predicted from those obtained with homologous tumor mixtures ( Combining suicide gene therapy with gene therapy employing connexin gap junction proteins
Because it appeared that the GJIC of the nontransduced tumor population dictated the degree of tumor burden reduction with suicide gene therapy, an alternative method to enhance the bystander effect by increasing the expression of gap junction proteins was explored. A double therapy combining HSV-TK /GCV therapy with that employing gene therapy with Cx43 was tested. For these experiments, the HT29 -TK and the HT29 colorectal tumor cell line, which consistently tested as one with a low GJIC ( 2% to 8% ) by double dye transfer assay, was transduced with the 
Discussion
For suicide gene therapy to be effective, transduction of every tumor cell is not required due to bystander cell effects. The efficacy observed, beyond that which would occur from the expected as calculated from in situ transduction rate, has been termed the bystander effect. 4,6,7,13 -17 In this report we extended our studies to include other HSV-TK -transduced murine and human glioma, melanoma, and colorectal cell lines and compared their bystander killing effects in vitro and in vivo and assessed their GJIC.
In prior work we demonstrated that established rat 9L gliosarcoma tumors could be successfully treated with HSV-TK retroviral particle gene transfer and systemic GCV. 10 By contrast, animals receiving either reagent alone displayed progressive lethal tumor growth. Interestingly, regressing tumors were heavily infiltrated with CD4 and CD8 positive cells, suggesting a cellular immune response to syngeneic brain tumors treated by gene therapy. We also demonstrated in tumor volumetric studies that 89% of fully transduced 9L -TK tumors treated with GCV responded to treatment. 11 Additionally, 50% of those animals with 1 -week established 9L tumors responded when treated in situ with HSV-TK retroviral particles followed by GCV administration; survival studies of the like experimental group showed 38% alive at 60 days. Suicide gene therapy was effective in vivo when the established tumor burden was low, but with higher tumor burden it was less so, presumably because of incomplete or inappropriate delivery of the TK gene to cells throughout the total tumor burden.
We now believe that approaches involving superinfection with retroviral vectors or transduction with adenoviral vectors to increase intracellular levels of TK may not improve bystander killing. Indeed, C6 -TK cells that expressed 10-fold higher levels of TK protein as DM12-TK (F Burrows, W Smiley), were no better at killing DM12 cells than DM12 -TK ( Table 1) . For this same reason intralesional injection of super TK positive cells also may not be a fruitful approach to improving the efficacy of HSV-TK retroviral gene therapy.
Similar to the 9L cell line, 11 when C6 HSV-TKtransduced glioma cells were mixed with nontransduced parental cells, treatment with GCV resulted in much greater tumor cell death, especially when cell -cell contact was maximized (Fig 2A ) . Substantial bystander effects also were seen with C6 -TK cells in the admixtures plated at low cell density (Fig 2B ) . These latter data indicated that transfer of soluble toxic GCV triphosphate metabolites occurred or induction of apoptosis was stimulated by the cell death occurring in the TK + population of cells.
Because cell density maximized the bystander effects, it was reasonable to focus attention on one or more mechanisms affecting the cell to cell communication at the gap junction. The results of a double dye transfer assay indicated that among glioma, melanoma, and colorectal cell lines, it was the glioma cells with the highest GJIC (Fig 3 ) . Further, quantitative in vitro assay results ( Table 1 ) and in vivo tumor volumetric data ( Table 2 ) demonstrated that compared to melanoma cell lines, it was the glioma cell lines that showed greater bystander cell death. Cumulatively, one could make the argument that the suicide gene paradigm may be particularly effective against malignant glioma.
Published data indicate that cross -species GJIC occurs in vitro ( mouse -rat, mouse -human ). 18 In our experiments all interspecific GJIC seemed to be as efficient as intraspecific GJIC, suggesting that mixing experiments with cells from different species yield interpretable data.
In tumor cell mixing experiments, we explored the practical opportunities for harnessing the power of bystander killing to improve clinical outcomes for human brain tumors. Experiments were designed to determine if GJIC capability was more important in the TK + (transduced ) or TK À ( bystander ) cell populations. In vitro quantitative assays ( Fig 4) and in vivo tumor volumetric analyses of chimeric or homologous tumor mixtures ( Figs 4 and 5, Table 1 ) provided substantial evidence that the bystander effect achieved was characteristic of the nontransduced ( bystander ) cell line. Because CNS -1 -TK and DM12-TK have similar GCV sensitivity ( IC 50 =1 g/mL, F Burrows, W Smiley ), it is likely that the differences observed in bystander killing are due to differences in GJIC. We attempted to manipulate the conditions supporting a gap junction mechanism in facilitating bystander effects. It was plausible that combination therapy with a vector that delivers a gap junction gene, such as Cx43, could confer the high bystander phenotype without further improvement being needed in the delivery or expression of the TK gene. We presented supporting evidence of this idea in Figure 5 , where nontransduced, high -GJIC cells in a chimeric tumor mass effectively bridged between transduced tumor cells and poorly communicating nontransduced cells. These results suggested that a double therapy employing HSV-TK retroviral vectors and another viral vector containing a transgene conferring high GJIC (i.e., connexin ) could have synergistic antitumor activity on treatment with GCV. Data shown in Figure 6 exploring this multimodal approach indicates gap junction proteins play a role in facilitating further reduction of tumor burden.
In the HSV-TK /GCV gene therapy model, bystander cell death is widely believed to result from uptake of toxic GCV triphosphate by nontransduced cells.
19,20 Although we are not alone in suggesting that gap junction proteins and GJIC play an important role in bystander cell death, 15,16,20 -23 other mechanisms have been suggested to account for bystander effects in vitro and in vivo. In one mechanism the induction of apoptosis in neighboring, nontransduced cells is due to the exchange of cytotoxic soluble factors or endocytosis of toxic cell debris from dying cells. 24 -27 In another mechanism a cellular immune response involving T lymphocytes and /or release of cytokines is postulated, and in some cases, immunization factors combined with suicide gene therapy produced a more beneficial result than either therapy used alone. 10,28 -36 Yet another mechanism involves destruction of HSV-TKtransduced endothelial cells, which are part of the tumor vasculature. 37, 38 A complete understanding of bystander cell death in vivo is presently lacking. It is clear, however, that certain tumor types are more responsive to bystander effects from HSV-TK /GCV treatment than are others. We have shown that the efficacy of treatment by suicide gene therapy is best when cells have a high GJIC. It is also plausible, especially in tumor cells having low GJIC, that combining suicide gene therapy with gene therapy to enhance expression of gap junction proteins may further reduce tumor burden.
